Search Within

George Raptis

  1. "Behavioral Sciences Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Behavioral Sciences Service (13)
  3. Breast Medicine Service (13)
  4. Department of Medicine (13)
  5. Psychiatry and Behavioral Sciences, Department of (13)
  6. Solid Tumor Oncology Division (13)

More Groups

People
  1. Clifford Hudis (13)
  2. Larry Norton (13)
  3. Teresa Gilewski (13)
  4. Andrew Seidman (12)
  5. David Fennelly (10)
  6. Jose Baselga (10)

More People

Years
  1. 1999 (3)
  2. 1998 (1)
  3. 1997 (1)
  4. 1996 (3)
  5. 1995 (3)
  6. 1994 (2)
Publications
  1. Breast Cancer Research and Treatment (3)
  2. Journal of Clinical Oncology (3)
  3. Seminars in Oncology (2)
  4. Blood (1)
  5. Cancer Investigation (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (3)
  3. Springer (3)
  4. American Association for Cancer Research (2)
  5. American Society of Hematology (1)
  6. Informa Healthcare (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
    Journal Article

    Hudis, C.; Seidman, A.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Moynahan, M.; Sklarin, N.; Fennelly, D.; Crown, J. P. A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Phase II study of semisynthetic paclitaxel in metastatic breast cancer
    Journal Article

    Hudis, C.; Riccio, L.; Holmes, F.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Moynahan, M.; Raptis, G.; more...
    European Journal of Cancer (1997)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Hudis, C.; Seidman, A.; Raptis, G.; Fennelly, D.; Gilewski, T.; Baselga, J.; Theodoulou, M.; Sklarin, N.; Moynahan, M.; Surbone, A.; more...
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Crown, J. P. A.; Balmaceda, C.; Freilich, R.; Gilewski, T. A.; Hakes, T. B.; Currie, V.; Lebwohl, D. E.; Baselga, J.; more...
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (etx) followed by paclitaxel (ptx): A design based on in vitro (IV) synergy in patients with advanced breast cancer
    Meeting Abstract

    Fennelly, D.; Gilewski, T.; Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save